|
Lipids and Lipid Disorders
Contributing journals to this collection:
JAMA & Archives Journals
Citations 531-540 of 550 total displayed.
- Original Contributions
Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
- Benoît Lamarche; André Tchernof; Pascale Mauriège; Bernard Cantin; Gilles R. Dagenais; Paul J. Lupien; Jean-Pierre Després
JAMA 1998; 279: 1955-1961.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Effect of a Garlic Oil Preparation on Serum Lipoproteins and Cholesterol Metabolism: A Randomized Controlled Trial
- Heiner K. Berthold; Thomas Sudhop; Klaus von Bergmann
JAMA 1998; 279: 1900-1902.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Mediterranean Dietary Pattern in a Randomized Trial: Prolonged Survival and Possible Reduced Cancer Rate
- Michel de Lorgeril; Patricia Salen; Jean-Louis Martin; Isabelle Monjaud; Philippe Boucher; Nicolle Mamelle
Arch Intern Med 1998; 158: 1181-1187.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Garlic Powder and Plasma Lipids and Lipoproteins: A Multicenter, Randomized, Placebo-Controlled Trial
- Jonathan L. Isaacsohn; Marvin Moser; Evan A. Stein; Karen Dudley; Janice A. Davey; Ellen Liskov; Henry R. Black
Arch Intern Med 1998; 158: 1189-1194.
[Abstract]
[Full text]
[PDF]
- Corrections
Error in Figure Legends
-
Arch Intern Med 1998; 158: 1228.
[Full text]
[PDF]
- Original Investigations
Primary Care Practice Adherence to National Cholesterol Education Program Guidelines for Patients With Coronary Heart Disease
- Patrick McBride; Helmut G. Schrott; Mary Beth Plane; Gail Underbakke; Roger L. Brown
Arch Intern Med 1998; 158: 1238-1244.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH
- Henry Buchwald; Richard L. Varco; James R. Boen; Stanley E. Williams; Betty J. Hansen; Christian T. Campos; Gilbert S. Campbell; Malcolm B. Pearce; Albert E. Yellin; W. Allan Edmiston; Robert D. Smink Jr; Henry S. Sawin Jr; for the POSCH Group
Arch Intern Med 1998; 158: 1253-1261.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
- John R. Downs; Michael Clearfield; Stephen Weis; Edwin Whitney; Deborah R. Shapiro; Polly A. Beere; Alexandra Langendorfer; Evan A. Stein; William Kruyer; Antonio M. Gotto Jr; for the AFCAPS/TexCAPS Research Group
JAMA 1998; 279: 1615-1622.
[Abstract]
[Full text]
[PDF]
- Commentaries
Lipid-Lowering Therapy in Low-Risk Patients
- Thomas A. Pearson
JAMA 1998; 279: 1659-1661.
[Extract]
[Full text]
[PDF]
- Original Contributions
Persistence of Use of Lipid-Lowering Medications: A Cross-National Study
- Jerry Avorn; Johanne Monette; Anne Lacour; Rhonda L. Bohn; Mark Monane; Helen Mogun; Jacques LeLorier
JAMA 1998; 279: 1458-1462.
[Abstract]
[Full text]
[PDF]
|
Advertisement


|
|
|